Grutters JC - Search Results

1

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.

Vancheri C, Kreuter M, Richeldi L, Ryerson CJ, Valeyre D, Grutters JC, Wiebe S, Stansen W, Quaresma M, Stowasser S, Wuyts WA; INJOURNEY Trial Investigators. Vancheri C, et al. Among authors: grutters jc. Am J Respir Crit Care Med. 2018 Feb 1;197(3):356-363. doi: 10.1164/rccm.201706-1301OC. Am J Respir Crit Care Med. 2018. PMID: 28889759 Clinical Trial.

2

[Idiopathic pulmonary fibrosis; description of a Dutch cohort].

Barlo NP, van Moorsel CH, van den Bosch JM, van de Graaf EA, Kwakkel-van Erp JM, Grutters JC. Barlo NP, et al. Among authors: grutters jc. Ned Tijdschr Geneeskd. 2009;153:B425. Ned Tijdschr Geneeskd. 2009. PMID: 19785823 Dutch.

3

Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis.

Barlo NP, van Moorsel CH, Ruven HJ, Zanen P, van den Bosch JM, Grutters JC. Barlo NP, et al. Among authors: grutters jc. Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):155-61. Sarcoidosis Vasc Diffuse Lung Dis. 2009. PMID: 20560296

4

Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort.

van Moorsel CH, van Oosterhout MF, Barlo NP, de Jong PA, van der Vis JJ, Ruven HJ, van Es HW, van den Bosch JM, Grutters JC. van Moorsel CH, et al. Among authors: grutters jc. Am J Respir Crit Care Med. 2010 Dec 1;182(11):1419-25. doi: 10.1164/rccm.200906-0953OC. Epub 2010 Jul 23. Am J Respir Crit Care Med. 2010. PMID: 20656946

5

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.

Korthagen NM, van Moorsel CH, Barlo NP, Ruven HJ, Kruit A, Heron M, van den Bosch JM, Grutters JC. Korthagen NM, et al. Among authors: grutters jc. Respir Med. 2011 Jan;105(1):106-13. doi: 10.1016/j.rmed.2010.09.012. Respir Med. 2011. PMID: 20888745 Free article.

6

Predicting prognosis in idiopathic pulmonary fibrosis.

Barlo NP, van Moorsel CH, van den Bosch JM, Grutters JC. Barlo NP, et al. Among authors: grutters jc. Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):85-95. Sarcoidosis Vasc Diffuse Lung Dis. 2010. PMID: 21319590 Review.

7

[High mortality in patients with idiopathic pulmonary fibrosis on Dutch lung transplant waiting list].

ten Klooster L, van Moorsel CH, van Hal PT, van den Blink B, Nossent GD, Verschuuren EA, Kwakkel-van Erp JM, van de Graaf EA, van Kessel DA, Grutters JC. ten Klooster L, et al. Among authors: grutters jc. Ned Tijdschr Geneeskd. 2012;156(2):A3752. Ned Tijdschr Geneeskd. 2012. PMID: 22236616 Dutch.

8

Association between variations in cell cycle genes and idiopathic pulmonary fibrosis.

Korthagen NM, van Moorsel CH, Barlo NP, Kazemier KM, Ruven HJ, Grutters JC. Korthagen NM, et al. Among authors: grutters jc. PLoS One. 2012;7(1):e30442. doi: 10.1371/journal.pone.0030442. Epub 2012 Jan 23. PLoS One. 2012. PMID: 22291954 Free PMC article.

9

Methotrexate vs azathioprine in second-line therapy of sarcoidosis.

Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M, Thomeer M, van Moorsel CHM, Grutters JC. Vorselaars ADM, et al. Among authors: grutters jc. Chest. 2013 Sep;144(3):805-812. doi: 10.1378/chest.12-1728. Chest. 2013. PMID: 23538719

10

Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a time.

Spagnolo P, Luppi F, Maher TM, Wuyts WA, Grutters JC. Spagnolo P, et al. Among authors: grutters jc. Am J Respir Crit Care Med. 2013 Jun 1;187(11):1271-2. doi: 10.1164/rccm.201209-1755LE. Am J Respir Crit Care Med. 2013. PMID: 23725621 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page